bibliographic resource 861716 [br/861716]
https://w3id.org/oc/corpus/br/861716

is a

• document
• article

title

• Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206

publication date

• 2010-01-01

contributor

• https://w3id.org/oc/corpus/ar/2770809
• https://w3id.org/oc/corpus/ar/2770810
• https://w3id.org/oc/corpus/ar/2770811
• https://w3id.org/oc/corpus/ar/2770812
• https://w3id.org/oc/corpus/ar/2770813
• https://w3id.org/oc/corpus/ar/2770814
• https://w3id.org/oc/corpus/ar/2770815
• https://w3id.org/oc/corpus/ar/2770816
• https://w3id.org/oc/corpus/ar/2770817
• https://w3id.org/oc/corpus/ar/2770818
• https://w3id.org/oc/corpus/ar/2770819
• https://w3id.org/oc/corpus/ar/2770820

format

• https://w3id.org/oc/corpus/re/387265

identifier

• https://w3id.org/oc/corpus/id/1420902
• https://w3id.org/oc/corpus/id/1420903
• https://w3id.org/oc/corpus/id/1420904
• https://w3id.org/oc/corpus/id/1420905

part of

• https://w3id.org/oc/corpus/br/77641